{"disease":{"id":"immune-checkpoint-inhibitor-monotherapy-or-combined-with-molecular-targeting-drugs-locoregional-therapy-for-hepatocellular-carcinoma","name":"immune checkpoint inhibitor monotherapy or combined with molecular targeting drugs locoregional therapy for hepatocellular carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05609695","title":"Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}